0001193125-19-234192.txt : 20190829 0001193125-19-234192.hdr.sgml : 20190829 20190829173021 ACCESSION NUMBER: 0001193125-19-234192 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20190823 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190829 DATE AS OF CHANGE: 20190829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL PROPERTIES TRUST INC CENTRAL INDEX KEY: 0001287865 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32559 FILM NUMBER: 191067359 BUSINESS ADDRESS: STREET 1: 1000 UBRAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: 1000 URBAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPT Operating Partnership, L.P. CENTRAL INDEX KEY: 0001524607 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-177186 FILM NUMBER: 191067358 BUSINESS ADDRESS: STREET 1: MEDICAL PROPERTIES TRUST, INC. STREET 2: 1000 URBAN CENTER DRIVE, SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: MEDICAL PROPERTIES TRUST, INC. STREET 2: 1000 URBAN CENTER DRIVE, SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 8-K 1 d14611d8k.htm FORM 8-K Form 8-K
false00012878650001524607MEDICAL PROPERTIES TRUST INC 0001287865 2019-08-23 2019-08-23 0001287865 mpw:MptOperatingPartnershipLpMember 2019-08-23 2019-08-23
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM
8-K
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 23, 2019
 
MEDICAL PROPERTIES TRUST, INC.
MPT OPERATING PARTNERSHIP, L.P.
(Exact Name of Registrant as Specified in Charter)
 
         
Maryland
Delaware
 
001-32559
333-177186
 
20-0191742
20-0242069
(State or other jurisdiction of
incorporation or organization)
 
(Commission
File Number)
 
(I. R. S. Employer
Identification No.)
 
 
 
 
 
 
 
 
 
 
 
 
 
1000 Urban Center Drive, Suite 501
Birmingham, AL 35242
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (205)
969-3755
 
 
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securities registered pursuant to Section 12(b) of the Securities Act:
         
Title of each class
 
Trading
Symbols(s)
 
Name of each exchange
on which registered
Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.
 
MPW
 
The New York Stock Exchange
 
 
 
 
 
 
 
 
 
 
 
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule
12b-2
of the Securities Exchange Act of 1934 (17 CFR §
240.12b-2).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
     
 
 
 
 
 
 
 
 
 
Item 1.01.
Entry into a Material Definitive Agreement.
 
 
 
 
 
 
The disclosures contained in “Item 2.01 Completion of Acquisition or Disposition of Assets” of this Current Report on Form
8-K
are incorporated into this Item 1.01 by reference.
Item 2.01
Completion of Acquisition or Disposition of Assets.
 
 
 
 
 
 
On August 23, 2019, affiliates of Medical Properties Trust, Inc. (the “Company”) and MPT Operating Partnership, L.P. (the “Operating Partnership”, and together with the Company and its consolidated subsidiaries, “we” or “our”) completed the previously announced $1.55 billion investment in 14 hospitals and two behavioral health facilities operated by Prospect Medical Holdings, Inc. (“Prospect”). Pursuant to the terms of an asset purchase agreement with Prospect, dated July 11, 2019, certain subsidiaries of the Operating Partnership acquired from Prospect all of its interests in the real estate of 11 acute care hospitals and two behavioral health facilities for an aggregate purchase price of approximately $1.4 billion. Such hospitals and facilities were leased back to Prospect under two separate master leases. In addition, (i) a subsidiary of the Operating Partnership made a mortgage loan in the amount of approximately $51.3 million, secured by a first mortgage on an acute care hospital, and (ii) a subsidiary of the Company’s taxable REIT subsidiary made a term loan of approximately $112.9 million, which will mature upon the earlier of three years or the satisfaction of certain conditions. After the maturity of the term loan and upon satisfaction of certain conditions, other subsidiaries of the Operating Partnership will acquire from Prospect all of its interests in the real estate of two additional acute care hospitals, which real estate will be added to one of the master leases. The master leases, mortgage loan, and term loan are cross-defaulted and cross-collateralized. The master leases and mortgage loan have substantially similar terms, with a
15-year
fixed term subject to three extension options, plus annual increases based on inflation.
The table below sets forth pertinent details with respect to the hospitals and behavioral health facilities in the Prospect portfolio:
                                         
Hospital
 
City
   
State
   
Form of
Investment
   
Hospital Type
   
Licensed
Beds
 
Southern CA Hospital at Hollywood
   
Los Angeles
     
California
     
Fee Simple
     
Acute
     
100
 
Southern CA Hospital at Van Nuys
   
Van Nuys
     
California
     
Fee Simple
     
Behavioral
     
57
 
Southern CA Hospital at Culver City
   
Culver City
     
California
     
Fee Simple
     
Acute
     
420
 
Los Angeles Community Hospital at Norwalk
   
Norwalk
     
California
     
Fee Simple
     
Acute
     
50
 
Los Angeles Community Hospital
   
Los Angeles
     
California
     
Fee Simple
     
Acute
     
129
 
Los Angeles Community Hospital at Bellflower
   
Bellflower
     
California
     
Fee Simple
     
Behavioral
     
144
 
Foothill Regional Medical Center
   
Tustin
     
California
     
Mortgage Loan
     
Acute
     
177
 
Manchester Memorial Hospital
   
Manchester
     
Connecticut
     
Fee Simple
     
Acute
     
249
 
Rockville General Hospital
   
Vernon
     
Connecticut
     
Fee Simple
     
Acute
     
102
 
Waterbury Hospital
   
Waterbury
     
Connecticut
     
Fee Simple
     
Acute
     
357
 
Crozer-Chester
Medical Center
   
Upland
     
Pennsylvania
     
Fee Simple
     
Acute
     
300
 
Springfield Hospital
   
Springfield
     
Pennsylvania
     
Fee Simple
     
Acute
     
25
 
Taylor Hospital
   
Ridley Park
     
Pennsylvania
     
Fee Simple
     
Acute
     
105
 
Delaware County Memorial Hospital
   
Drexel Hill
     
Pennsylvania
     
Fee Simple
     
Acute
     
168
 
                                         
Total Licensed Beds*
   
     
     
     
     
2,383
 
                                         
 
 
 
 
 
 
 
 
* Excludes two properties subject to a delayed closing depending upon satisfaction of certain conditions.
 
 
 
 
 
 
The agreements provide for the potential for a future purchase price adjustment of up to an additional $250.0 million based on achievement of certain performance thresholds over a three-year period. Any such adjustment will be added to the lease base upon which the Company will earn a return in accordance with the master leases.
The Company financed the transaction with a combination of unsecured debt and securities issuances.
Item 7.01.
Regulation FD Disclosure.
 
 
 
 
 
 
On August 26, 2019, we issued a press release announcing closing of the transactions described above in Item 2.01 of this Current Report on Form
 8-K.
A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
The information contained in this Item 7.01 is being “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise. The information in this Item 7.01 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or into any filing or other document pursuant to the Securities Exchange Act of 1934, as amended, except as otherwise expressly stated in any such filing.
 
 
Item 9.01.
Financial Statements and Exhibits.
 
 
(d) Exhibits.
 
 
         
Exhibit
No.
   
Description
         
 
99.1
   
         
 
104
   
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 
 
 
 
 
 
 
 
 
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized.
     
MEDICAL PROPERTIES TRUST, INC.
     
By:
 
/s/ R. Steven Hamner
Name:
 
R. Steven Hamner
Title:
 
Executive Vice President and Chief
Financial Officer
 
 
 
 
 
 
Date: August 29, 2019
     
MPT OPERATING PARTNERSHIP, L.P.
     
By:
 
/s/ R. Steven Hamner
Name:
 
R. Steven Hamner
Title:
 
Executive Vice President and Chief Financial Officer
of the sole member of the general partner of MPT
Operating Partnership, L.P.
 
 
 
 
 
 
Date: August 29, 2019
EX-99.1 2 d14611dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

    

Contact: Tim Berryman

    

Director – Investor Relations

    

Medical Properties Trust, Inc.

    

(205) 969-3755

tberryman@medicalpropertiestrust.com

MEDICAL PROPERTIES TRUST COMPLETES INVESTMENTS OF APPROXIMATELY $2.0 BILLION IN RAMSAY AND PROSPECT HOSPITALS

Birmingham, AL – August 26, 2019 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that it completed on August 16 and August 23, respectively, the acquisitions of the real estate interests of eight UK hospitals operated by Ramsay Health Care and 16 hospitals operated by Prospect Medical Holdings, Inc.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to acquire and develop net-leased hospital facilities. MPT’s financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.

The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as “expects,” “believes,” “anticipates,” “intends,” “will,” “should” and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: the satisfaction of all conditions to, and the timely closing (if at all) of pending transactions; the amount of acquisitions of healthcare real estate, if any; results from potential sales and joint venture arrangements, if any; capital markets conditions; estimated leverage metrics; the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in equity investments and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangements, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company’s business plan; financing risks; the Company’s ability to maintain its status as a REIT for income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the “Risk factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.

# # #

 

1

EX-101.SCH 3 mpw-20190823.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 4 mpw-20190823_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 5 mpw-20190823_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 mpw-20190823_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 7 mpw-20190823_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 g14611g0829225640311.jpg GRAPHIC begin 644 g14611g0829225640311.jpg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end XML 9 d14611d8k_htm.xml IDEA: XBRL DOCUMENT 0001287865 2019-08-23 2019-08-23 0001287865 mpw:MptOperatingPartnershipLpMember 2019-08-23 2019-08-23 false 0001287865 0001524607 MEDICAL PROPERTIES TRUST INC 8-K 2019-08-23 MPT OPERATING PARTNERSHIP, L.P. MD DE 001-32559 333-177186 20-0191742 20-0242069 1000 Urban Center Drive 1000 Urban Center Drive Suite 501 Suite 501 Birmingham Birmingham AL AL 35242 35242 205 205 969-3755 969-3755 false false false false Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc. MPW NYSE false XML 10 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Document and Entity Information
Aug. 23, 2019
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Entity Central Index Key 0001287865
Document Period End Date Aug. 23, 2019
Entity Registrant Name MEDICAL PROPERTIES TRUST INC
Entity File Number 001-32559
Entity Incorporation, State or Country Code MD
Entity Tax Identification Number 20-0191742
Entity Address, Address Line One 1000 Urban Center Drive
Entity Address, Address Line Two Suite 501
Entity Address, City or Town Birmingham
Entity Address, State or Province AL
Entity Address, Postal Zip Code 35242
City Area Code 205
Local Phone Number 969-3755
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.
Trading Symbol MPW
Security Exchange Name NYSE
MPT Operating Partnership LP [Member]  
Document Information [Line Items]  
Entity Central Index Key 0001524607
Entity Registrant Name MPT OPERATING PARTNERSHIP, L.P.
Entity File Number 333-177186
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 20-0242069
Entity Address, Address Line One 1000 Urban Center Drive
Entity Address, Address Line Two Suite 501
Entity Address, City or Town Birmingham
Entity Address, State or Province AL
Entity Address, Postal Zip Code 35242
City Area Code 205
Local Phone Number 969-3755
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 2 97 1 false 1 0 false 0 false false R1.htm 1001 - Document - Document and Entity Information Sheet http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d14611d8k.htm d14611dex991.htm mpw-20190823.xsd mpw-20190823_cal.xml mpw-20190823_def.xml mpw-20190823_lab.xml mpw-20190823_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d14611d8k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 2, "dts": { "calculationLink": { "local": [ "mpw-20190823_cal.xml" ] }, "definitionLink": { "local": [ "mpw-20190823_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "d14611d8k.htm" ] }, "labelLink": { "local": [ "mpw-20190823_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "mpw-20190823_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "mpw-20190823.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 1, "memberStandard": 0, "nsprefix": "mpw", "nsuri": "http://www.medicalpropertiestrust.com/20190823", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d14611d8k.htm", "contextRef": "P08_23_2019To08_23_2019", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Document and Entity Information", "role": "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d14611d8k.htm", "contextRef": "P08_23_2019To08_23_2019", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 1, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "mpw_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.medicalpropertiestrust.com/20190823", "xbrltype": "stringItemType" }, "mpw_MptOperatingPartnershipLpMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MPT Operating Partnership, L.P. [Member].", "label": "MPT Operating Partnership LP [Member]" } } }, "localname": "MptOperatingPartnershipLpMember", "nsuri": "http://www.medicalpropertiestrust.com/20190823", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 18 0001193125-19-234192-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-19-234192-xbrl.zip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